{"title":"头孢他啶+阿维巴坦治疗耐碳青霉烯肠杆菌所致合并菌血症的院内肺炎的药物经济学评价","authors":"S. K. Zyryanov, I. Dyakov","doi":"10.17116/medtech20204002150","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18386,"journal":{"name":"Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)","volume":"61 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Pharmacoeconomic evaluation of ceftazidime + avibactam administration in the treatment of nosocomial pneumonia caused by carbapenem-resistant Enterobacteriacea and complicated by bacteremia\",\"authors\":\"S. K. Zyryanov, I. Dyakov\",\"doi\":\"10.17116/medtech20204002150\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":18386,\"journal\":{\"name\":\"Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)\",\"volume\":\"61 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17116/medtech20204002150\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/medtech20204002150","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pharmacoeconomic evaluation of ceftazidime + avibactam administration in the treatment of nosocomial pneumonia caused by carbapenem-resistant Enterobacteriacea and complicated by bacteremia